Christina Merakou, PhD 🦠

EU-track EUPHEM fellow @istsupsan #ECDC | @harvardmed postdoc alumni and @Mariecurie_alumn | views are my own

[Vítor Borges @borges__vitor]

Only 3 days left to join the #Webinar on the Introduction to #INSaFLU-#TELEVIR (https://t.co/JRPcxOUWIT), an open bioinformatics platform for viral metagenomic detection and genomic surveillance.

📅 29th Oct 2024 | 10:00-12:00 CET

Register at ECDC EVA: https://t.co/yLhXdz6BgJ

[Sylvain Brisse @sylvainbrisse]

Out in @biorxiv_micrbio ! The evolutionary history of #Bordetella parapertussis in face of #whooping cough vaccination https://t.co/XWCIRck1v3

[Imperial Department of Infectious Disease @ImperialInfect]

Congratulations to @CBRB_Imperial who have appointed two co-directors. 🎉

Prof Mariagrazia Pizza and Prof Shiranee Sriskandan (@Grampospath) will lead the centre which focuses on bacterial discovery research including tackling antimicrobial resistance.👇
https://t.co/a9sDkDSweE

[Nicki Lynskey @LynskeyLab]

Super excited to share our first paper from the lab 🥳 A real team effort with great work from @juevalves, @ConnorB_micro, Josh Rand and Alix Johnston. https://t.co/E5DBsXnwEp

[Dan Davis @dandavis101]

I’m thrilled to let you know that we have just recruited a new professor to join our department: Prof. Mariagrazia Pizza. She is one of the world’s most accomplished researchers in vaccine development. @ImperialSci @ImperialLifeSci

[Christina Merakou, PhD 🦠 @xmerbug]

@SalmantonGarcia @usal @IBSAL_IIS Congratulations!!!

[Christina Merakou, PhD 🦠 @xmerbug]

#ESCAIDE2022 starting now! Tune in!

[Epiet Alumni Network @EANBoard]

Two exciting days of #media and #infodemic management are behind the 25 current fellows and alumni of our latest @EANBoard mini-module. Thanks to our speakers @e_milymey @frabad and @Mark_Brealey all facilitators, organisers and participants
#FETP #EPIET #EUPHEM #PAE

[Camille Jacqueline @CamilleJcqln]

Here we go! One day in the lab with me to celebrate #WorldFieldEpidemiologyDay !

[Benjamin Podbilewicz @Podbilewicz_lab]

Discovery of archaeal fusexins homologous to eukaryotic HAP2/GCS1 gamete fusion proteins | Nature Communications https://t.co/h5yFpyZeVQ

[Christina Merakou, PhD 🦠 @xmerbug]

"Critical care nurse in New York is among the first to receive the COVID-19 vaccine in the US" https://t.co/0gDczwwb5I

[Tom Sandora @tomsandora]

The Nobel Prize in medicine was awarded to 3 scientists who discovered Hepatitis C virus. Always great to see the importance of Infectious Diseases recognized! I love being an ID doc. #IDtwitter #hepatitisC
https://t.co/BewNQEDTAc

[Marc Lipsitch @mlipsitch]

Potential Biases Arising from Epidemic Dynamics in Observational Seroprotection Studies with ⁦@rebeccajk13 ⁦@yhgrad⁩ ⁦@LeeKShaffer Jamie Robins ⁩ | American Journal of Epidemiology | Oxford Academic ⁦ https://t.co/AKFYX6JHNZ

[Tom Sandora @tomsandora]

Proud that @BostonChildrens is an @IDSAInfo Antimicrobial Stewardship Center of Excellence! Led by @MariNakamura and Sarah Jones (ID pharmacist superstar), our ASP does incredible work to optimize antibiotic use. Shout out also to our former ASP director @kflett142.

[Ash Paul @pash22]

The 'iceberg' problem: how testing policy affects Covid-19 #coronavirus death rates

[Feng Zhang @zhangf]

Excited to announce HowWeFeel, an open platform for helping us fight the pandemic. Grateful for collaboration w/ @8en @XihongLin @kinggary @ophirshalem @GreeneScientist @bitdrift @rpjb and many other great colleagues. Visit https://t.co/zgRcHE6D2B. #COVID19Pandemic #coronavirus

[alexandre afonso @alexandreafonso]

Here is a distribution of recorded Covid-19 cases in Iceland (which tests broadly, even people with no symptoms) and the Netherlands (which tests narrowly, only those with severe symptoms)

[Imperial Department of Infectious Disease @ImperialInfect]

From vaccine development to mathematical models, learn more about the @imperialcollege women battling #COVID19 ✊ https://t.co/l3x8WV0QGZ

[Nature Medicine @NatureMedicine]

A new study estimates that the overall symptomatic case fatality risk - the probability of dying after developing symptoms of #COVID19 in Wuhan - was about 1.4%. Read now at https://t.co/JPlJKluQF2 @gmleunghku @mlipsitch @HKUniversity #SARSCoV2

[Christina Merakou, PhD 🦠 @xmerbug]

https://t.co/RFGpo1SCW7